A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X
Kenichi Ogiwara, Keiji Nogami, Naoki Matsumoto, Mariko Noguchi‐Sasaki, Michinori Hirata, Tetsuhiro Soeda, Midori Shima
Topics & Concepts
Bispecific antibodyThrombin generationTissue factorChemistryPartial thromboplastin timeThromboplastinCoagulationThrombinHematologyInternal medicineImmunologyAntibodyMedicinePlateletMonoclonal antibodyHemophilia Treatment and ResearchBlood Coagulation and Thrombosis MechanismsCoagulation, Bradykinin, Polyphosphates, and Angioedema